TriangleFOR PATIENTS · SOURCE READING
The use of drug therapy called highly active antiretroviral therapy (HAART) reduces the risk of epidemic Kaposi sarcoma in patients with HIV.
Source: Kaposi Sarcoma Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: May 17, 2023 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
HAART is a combination of several drugs used to lessen the damage to the immune system caused by HIV infection. Treatment with HAART reduces the risk of epidemic Kaposi sarcoma, although it is possible for a person to develop epidemic Kaposi sarcoma while taking HAART.
For information about AIDS and its treatment, see the HIVinfo website.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice